Related Experiment Videos
Prevalence of HIV-2 infection in Europe
Abstract:
The HIV/AIDS pandemic is primarily caused by HIV-1. Another type of virus, HIV-2, is found mainly in certain West African countries In Europe, most of the cases of HIV-2 infection described have been in people from Africa. The objective of this study was
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Preliminary results from the new HIV surveillance system in France.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2017
Recently acquired HIV infection in men who have sex with men (MSM) in France, 2003-2008.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2009
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) case reporting in the World Health Organization European Region in 2006.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008
Four years of surveillance of recent HIV infections at country level, France, mid 2003 - 2006: experience and perspectives.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2008
An outbreak of Panton-Valentine leucocidin-producing meticillin-resistant Staphylococcus aureus skin and soft tissue infection associated with bouncy castle use, Ireland, 2025.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Monitoring of cryptosporidiosis: a shift in circulating Cryptosporidium hominis subtypes, the Netherlands, 2016 to 2024.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Autochthonous chikungunya virus (CHIKV) outbreak in the province of Modena, Emilia-Romagna region, Italy, August to October 2025: epidemiology, clinical features and virological findings.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Multicentre outbreak of Candida viswanathii bloodstream infections linked to contaminated milrinone, Italy, April to October 2025.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
Emergence and spread of NA-I223V and NA-S247N double-mutant A(H1N1)pdm09 influenza viruses with reduced oseltamivir susceptibility in the Netherlands and beyond, 2023 to 2026.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026
A mark and recapture perspective on vaccination touchpoints.
Gates open research·2026
Management of Erythromelalgia: a narrative review and expert opinion.
Expert opinion on pharmacotherapy·2026
Influenza vaccine effectiveness in patients with chronic obstructive pulmonary disease: a cohort study emulating a randomized trial.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026